Clinical Trial Update: Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intranasal lorazepam with intramuscular paraldehyde in pediatric convulsions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seizures
• Status Epilepticus

Drugs mentioned

• intramuscular paraldehyde (paraldehyde)
• intranasal lorazepam (lorazepam)

Snippet

Sponsor: Kamuzu University of Health Sciences | Conditions: Status Epilepticus, Convulsions | Phase 3 | Status: COMPLETED